Lv4
780 积分 2024-10-25 加入
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)
10天前
已完结
Catastrophic healthcare expenditure and caregiver burden in pediatric chronic kidney disease — a mixed methods study from a low resource setting
10天前
已完结
The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression
10天前
已完结
The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression
10天前
已完结
司美格鲁肽对2型糖尿病合并高血压患者血压的影响
10天前
已完结
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
10天前
已完结
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
10天前
已完结
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
12天前
已完结
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
12天前
已完结
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
17天前
已完结
皖公网安备34019202002308
